Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: A meta-analysis of the liraglutide clinical trial programme

Aim: Effective type 2 diabetes management requires a multifactorial approach extending beyond glycaemic control. Clinical practice guidelines suggest targets for HbA1c, blood pressure and lipids, and emphasize weight reduction and avoiding hypoglycaemia. The phase 3 clinical trial programme for lira...

Description complète

Détails bibliographiques
Auteurs principaux: Zinman, B, Schmidt, W, Moses, A, Lund, N, Gough, S
Format: Journal article
Langue:English
Publié: 2012